Application note

Quantifying the Degradation of RBM39 in Neuroblastoma Cells Treated with Molecular Glue Degraders Using HTRF Technology

Get application note

See the potential of molecular glue degraders

RNA-binding motif protein 39 is a key factor in tumor-targeted RNA and protein expression that plays an important role in tumorigenesis. It’s important to study the interaction between RBM39 and tumors and the clinical application of drug-targeted therapy.

Download this application note, which highlights the use of HTRF immunoassays to evaluate RBM39 degradation in neuroblastoma cancer cells treated with Indilsulam and CeMM1-4 molecular glue degraders.

Fill this form

We are committed to your privacy. Revvity needs the contact information you provide us to keep you aware about relevant content, products, and services. You may unsubscribe from these communications at any time. For more information check out our  Privacy Policy.